Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Kinesin family member 20A is a novel melanoma-associated antigen.

Yamashita J, Fukushima S, Jinnin M, Honda N, Makino K, Sakai K, Masuguchi S, Inoue Y, Ihn H.

Acta Derm Venereol. 2012 Nov;92(6):593-7. doi: 10.2340/00015555-1416.

2.

Gene expression profiling of primary cutaneous melanoma and clinical outcome.

Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A; Melanoma Group of the European Organization for Research and Treatment of Cancer.

J Natl Cancer Inst. 2006 Apr 5;98(7):472-82.

3.

Prognostic significance of molecular staging study of sentinel lymph nodes by reverse transcriptase-polymerase chain reaction for tyrosinase in melanoma patients.

Mangas C, Hilari JM, Paradelo C, Rex J, Fernández-Figueras MT, Fraile M, Alastrue A, Ferrándiz C.

Ann Surg Oncol. 2006 Jul;13(7):910-8. Epub 2006 May 22.

PMID:
16788751
4.

Detection of melanoma cells in the lymphatic drainage after lymph node dissection in melanoma patients by using two-marker reverse transcriptase-polymerase chain reaction assay.

Włodzimierz R, Rutkowski P, Nowecki ZI, Kulik J, Nasierowska-Guttmejer A, Siedlecki JA.

Ann Surg Oncol. 2004 Nov;11(11):988-97. Epub 2004 Oct 15.

PMID:
15525828
5.

Cytokeratin expression in malignant melanoma: potential application of in-situ hybridization analysis of mRNA.

Chen N, Gong J, Chen X, Xu M, Huang Y, Wang L, Geng N, Zhou Q.

Melanoma Res. 2009 Apr;19(2):87-93. doi: 10.1097/CMR.0b013e3283252feb.

PMID:
19190520
6.

Downregulation of the retinoblastoma gene expression in the progression of malignant melanoma.

Korabiowska M, Ruschenburg I, Betke H, Stachura J, Schlott T, Cardo CC, Brinck U.

Pathobiology. 2001;69(5):274-80.

PMID:
12107345
7.

Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes.

Bieligk SC, Ghossein R, Bhattacharya S, Coit DG.

Ann Surg Oncol. 1999 Apr-May;6(3):232-40.

PMID:
10340881
8.

Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.

Nowecki ZI, Rutkowski P, Kulik J, Siedlecki JA, Ruka W.

Br J Dermatol. 2008 Sep;159(3):597-605. doi: 10.1111/j.1365-2133.2008.08710.x. Epub 2008 Jul 4.

PMID:
18616789
9.

RT in situ PCR detection of MART-1 and TRP-2 mRNA in formalin-fixed, paraffin-embedded tissues of melanoma and nevi.

Itakura E, Huang RR, Wen DR, Paul E, Wünsch PH, Cochran AJ.

Mod Pathol. 2008 Mar;21(3):326-33. doi: 10.1038/modpathol.3801008. Epub 2008 Jan 18.

10.

Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time rt-PCR.

Hilari JM, Mangas C, Xi L, Paradelo C, Ferrándiz C, Hughes SJ, Yueh C, Altomare I, Gooding WE, Godfrey TE.

Ann Surg Oncol. 2009 Jan;16(1):177-85. doi: 10.1245/s10434-008-0183-9. Epub 2008 Nov 4.

PMID:
18982394
11.

TRPM1 (Melastatin-1/MLSN1) mRNA expression in Spitz nevi and nodular melanomas.

Erickson LA, Letts GA, Shah SM, Shackelton JB, Duncan LM.

Mod Pathol. 2009 Jul;22(7):969-76. doi: 10.1038/modpathol.2009.56. Epub 2009 Apr 24.

12.

Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.

Vitoux D, Mourah S, Kerob D, Verola O, Basset-Seguin N, Baccard M, Schartz N, Ollivaud L, Archimbaud A, Servant JM, Revol M, Toubert ME, Podgorniak MP, Plassa F, Porcher R, Lebbé C.

Arch Dermatol. 2009 Oct;145(10):1105-13. doi: 10.1001/archdermatol.2009.209.

PMID:
19841396
13.
14.

Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.

Burton AL, Gilbert J, Farmer RW, Stromberg AJ, Hagendoorn L, Ross MI, Martin RC 2nd, McMasters KM, Scoggins CR, Callender GG.

Am Surg. 2011 Aug;77(8):1009-13.

PMID:
21944515
15.

Antigen Ki-67 and c-myc oncogene as related to histoclinical parameters in pigmented skin lesions.

Korabiowska M, Brinck U, Mirecka J, Kellner S, Marx D, Schauer A.

In Vivo. 1995 Sep-Oct;9(5):433-8.

PMID:
8900920
16.

Loss of EphB6 expression in metastatic melanoma.

Hafner C, Bataille F, Meyer S, Becker B, Roesch A, Landthaler M, Vogt T.

Int J Oncol. 2003 Dec;23(6):1553-9.

PMID:
14612926
17.

Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma.

Kunter U, Buer J, Probst M, Duensing S, Dallmann I, Grosse J, Kirchner H, Schluepen EM, Volkenandt M, Ganser A, Atzpodien J.

J Natl Cancer Inst. 1996 May 1;88(9):590-4.

18.

Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma.

Shakhova O, Zingg D, Schaefer SM, Hari L, Civenni G, Blunschi J, Claudinot S, Okoniewski M, Beermann F, Mihic-Probst D, Moch H, Wegner M, Dummer R, Barrandon Y, Cinelli P, Sommer L.

Nat Cell Biol. 2012 Aug;14(8):882-90. doi: 10.1038/ncb2535. Epub 2012 Jul 8.

PMID:
22772081
19.

Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection.

Rutkowski P, Nowecki ZI, Kulik J, Ruka W, Siedlecki JA.

Melanoma Res. 2008 Aug;18(4):246-52. doi: 10.1097/CMR.0b013e328307bf3f.

PMID:
18626308
20.

The prognostic value of a reverse transcriptase-PCR assay of sentinel lymph node biopsy for patients with cutaneous melanoma: a single-center analysis in Japan.

Ito T, Moroi Y, Oba J, Nakahara T, Takeuchi S, Uchi H, Takahara M, Masuda T, Furue M.

Melanoma Res. 2012 Feb;22(1):38-44. doi: 10.1097/CMR.0b013e32834dcfdf.

PMID:
22108607
Items per page

Supplemental Content

Write to the Help Desk